(Q43092106)

13 November 2017

title

Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

13 November 2017

0 references

1 reference

1 reference

Billur Canbakan

1

1 reference

13 November 2017

Hakan Senturk

2

1 reference

13 November 2017

Mustafa Canbakan

3

1 reference

13 November 2017

Tayfur Toptas

4

1 reference

13 November 2017

Omur Tabak

5

1 reference

13 November 2017

Huriye Balci

6

1 reference

13 November 2017

Vakur Olgac

7

1 reference

13 November 2017

Gulsen Ozbay

8

1 reference

13 November 2017

publication date

1 April 2010

1 reference

13 November 2017

published in

Biomarkers in Medicine

1 reference

13 November 2017

volume

4

1 reference

13 November 2017

issue

2

1 reference

13 November 2017

page(s)

205-214

1 reference

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

13 November 2017

cites work

1 reference

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

21 January 2018

1 reference

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

21 January 2018

1 reference

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury.

21 January 2018

1 reference

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

21 January 2018

1 reference

Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.

21 January 2018

1 reference

Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis

21 January 2018

1 reference

Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses.

21 January 2018

1 reference

The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse

21 January 2018

1 reference

Transaminase activity in human blood

21 January 2018

1 reference

The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

21 January 2018

1 reference

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

Mitochondria and apoptosis

21 January 2018

1 reference

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

21 January 2018

1 reference

Death receptors: signaling and modulation

21 January 2018

1 reference

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.

21 January 2018

1 reference

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

21 January 2018

1 reference

Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease

21 January 2018

1 reference

Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital

21 January 2018

1 reference

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease.

21 January 2018

1 reference

Death receptor-mediated apoptosis and the liver

21 January 2018

1 reference

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

21 January 2018

1 reference

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

21 January 2018

1 reference

Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice

21 January 2018

1 reference

Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

21 January 2018

1 reference

Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis.

21 January 2018

1 reference

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.09.88

1 reference

release_g5lzsktmhbezzkeqzburo34pce

13 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g5lzsktmhbezzkeqzburo34pce

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference